FDA Okays First Sublingual Med for Agitation in Serious Mental Illness

Published by Joseph Thornton MD

Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts